SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PLSE

Pulse Biosciences, Inc. (NASDAQ:PLSE)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$45.55+$1.14 (+2.57%)
 
Market cap
$3.35B
Insider Score
Health Score
Analyst consensus
Listed since
May 18, 2016
Market Cap$3.35B+248.0%
Revenue (ttm)$1.49M+1637.2%
Net Income-$83.72M-12.0%
EPS-$1.20-4.3%
Shares Out73.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume466,798
Open$44.84
Previous Close$44.41
Day's Range$44.62 - $46.03
52-Week Range$12.95 - $58.94
Beta1.64
AnalystsBuy
Price Target$63.40(+39.19%)
Earnings DateFeb 18, 2027

About PLSE

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.

Address
601 Brickell Key Drive, Miami, FL, 33131, US
Market Cap
3.35 billion
Employees
116
Industrial Classification
Medical - Instruments & Supplies

Pulse Biosciences, Inc. Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
55th Percentile Overall Score
PLSE InsiderScore:72 / 99

Pulse Biosciences, Inc. scored higher than 55% of companies evaluated by InsiderBuying, and ranked 24th out of 50 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Pulse Biosciences, Inc. bought $199.9K of stock across 4 purchases in the last 90 days, the largest of them $50.0K.

Stake Increase

The average purchase added about 59% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$3.02M
Bought
$13.50M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
3 Buy0 Hold0 SellAvg target $61.00 (+35.8%)

3 firms rating PLSE in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From PLSE’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
+2.57%
5 Days
-11.10%
1 Month
-13.53%
6 Months
+75.94%
1 Year
+247.98%

$PLSE stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in PLSE holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by PLSE's directors and management

Net Shares Purchased by Insiders−700k−350k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

PLSE Estimated quarterly lobbying spending

Source: U.S. Senate LDA

PLSE Revenue by Segment or Geography

PLSE's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New PLSE patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PLSE from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in PLSE

VTIVanguard Morningstar Total Stock Market ETF$28.43M
IWMiShares Russell 2000 ETF$22.06M
VXFVanguard Extended Market ETF$11.87M
IWOiShares Russell 2000 Growth ETF$7.98M
VTWOVanguard Russell 2000 ETF$5.80M
SCHASchwab U.S. Small-Cap ETF$4.62M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from PLSE’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
65.93
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
72

News check: Rating upgrade to Buy, positive study enrollment progress, and favorable analyst positioning outweigh valuation concerns from one headline.

Recent Insider Activity

Buys
6
Sells
8
Buy Value
$13.50M
Distinct Buyers
3

Insider Score Trend Over Time

-11.2 since Sep 24
0255075100Sep 24 — Insider Score 77.1Sep 25 — Insider Score 86.6Sep 26 — Insider Score 85.7Sep 27 — Insider Score 86.6Sep 28 — Insider Score 86.6Sep 29 — Insider Score 85.3Sep 30 — Insider Score 85.9Oct 1 — Insider Score 84.5Oct 2 — Insider Score 58.0Oct 3 — Insider Score 84.0Oct 4 — Insider Score 84.2Oct 5 — Insider Score 84.3Oct 6 — Insider Score 84.0Oct 7 — Insider Score 84.5Oct 8 — Insider Score 84.4Oct 9 — Insider Score 84.3Oct 10 — Insider Score 83.9Oct 11 — Insider Score 84.3Oct 12 — Insider Score 84.2Oct 13 — Insider Score 84.0Oct 14 — Insider Score 82.9Oct 15 — Insider Score 83.6Oct 16 — Insider Score 83.4Oct 17 — Insider Score 83.3Oct 18 — Insider Score 83.6Oct 19 — Insider Score 83.4Oct 20 — Insider Score 83.3Oct 21 — Insider Score 82.4Oct 22 — Insider Score 82.5Oct 23 — Insider Score 82.3Oct 24 — Insider Score 82.4Oct 25 — Insider Score 83.0Oct 26 — Insider Score 83.1Oct 27 — Insider Score 83.0Oct 28 — Insider Score 82.0Oct 29 — Insider Score 82.5Oct 30 — Insider Score 81.4Oct 31 — Insider Score 81.2Nov 1 — Insider Score 80.1Nov 2 — Insider Score 81.1Nov 3 — Insider Score 80.2Nov 4 — Insider Score 79.7Nov 5 — Insider Score 78.6Nov 6 — Insider Score 77.7Nov 7 — Insider Score 76.0Nov 8 — Insider Score 76.8Nov 9 — Insider Score 76.9Nov 10 — Insider Score 76.3Nov 11 — Insider Score 75.6Nov 12 — Insider Score 75.2Nov 13 — Insider Score 72.6Nov 14 — Insider Score 71.4Nov 15 — Insider Score 71.9Nov 16 — Insider Score 72.8Nov 17 — Insider Score 73.2Nov 18 — Insider Score 71.8Nov 19 — Insider Score 69.3Nov 20 — Insider Score 66.0Nov 21 — Insider Score 64.2Nov 22 — Insider Score 65.9Sep 24Oct 23Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

XHEState Street SPDR S&P Health Care Equipment ETF1.44%
PTHInvesco Dorsey Wright Healthcare Momentum ETF1.21%
PCSGPolen 5Perspectives Small-Mid Growth ETF0.92%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.40%
IWCiShares Micro-Cap ETF0.26%
TNXTT. Rowe Price Innovation Leaders ETF0.26%
ESSCEventide Small Cap ETF0.24%
ISMDInspire Small/Mid Cap ETF0.23%
FSCCFederated Hermes MDT Small Cap Core ETF0.18%
VFMOVanguard U.S. Momentum Factor ETF0.14%
IHIiShares U.S. Medical Devices ETF0.14%
VMO.TOVanguard Global Momentum Factor ETF0.08%

Weight is the stock’s share of each fund’s holdings.